---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-013638"
form_type: "8-K"
ticker: "FLNA"
cik: "0001069530"
company_name: "FILANA THERAPEUTICS, INC."
filed_at: "2026-04-28T23:59:59+00:00"
generated_at: "2026-05-15T02:41:25.311625+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Filana Therapeutics board member Michael O'Donnell resigns effective at 2026 annual meeting

## Summary
- Michael O'Donnell notified Filana's Board of his resignation on April 22, 2026.
- Resignation is effective at the conclusion of the 2026 annual meeting of stockholders.
- O'Donnell will continue to serve as a director until the effective date.
- Resignation was not due to any disagreement with Company, management, or Board.

## SEC filing metadata
- accession: 0001437749-26-013638
- form_type: 8-K
- ticker: FLNA
- cik: 0001069530
- company_name: FILANA THERAPEUTICS, INC.
- filed_at: 2026-04-28T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1069530/000143774926013638/0001437749-26-013638-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1069530/000143774926013638/sava20260427_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-013638
- JSON: https://secwatch.observer/filing/0001437749-26-013638.json
- Plain text: https://secwatch.observer/filing/0001437749-26-013638.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.